Research, Maternal, Child and Reproductive Health

MULTIPLY

MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention

Magburaka U5 Hospital in Tonkolili district, in Sierra Leone.
Photo: Waiting room at the Magburaka U5 Hospital, in Tonkolili district, Sierra Leone. (Anna Lucas)
Duration
01/05/2021 - 31/08/2024
Coordinator
Clara Menéndez
Funded by
The European & Developing Countries Clinical Trials Partnership (EDCTP)

As efforts to control malaria are stalling, and the disease is particularly severe in children under the age of two, it is imperative for countries in sub-Saharan Africa, with areas of moderate-to-high transmission, to implement Intermittent Preventive Treatment in infants (IPTi) delivered through the Expanded Program on Immunization (EPI), which is the only feasible, sustainable and cost-effective strategy to reach this high-risk group. IPTi has been shown to be safe, efficacious in reducing clinical malaria, anaemia and hospital admissions, and to be highly cost-effective since it is delivered alongside EPI and uses an inexpensive antimalarial drug (Sulfadoxine-Pyrimethamine); for all these reasons, the World Health Organisation recommends it for malaria prevention in infants. However, IPTi has not been implemented to date, except in Sierra Leone.

MULTIPLY is a large-scale implementation development cooperation project, which includes public and private European and African institutions aiming at maximising the delivery and uptake of IPTi, to achieve full potential and effectiveness of this intervention.

Research partners from Mozambique, Sierra Leone and Togo in selected country districts will conduct the implementation of IPTi at health facilities and EPI mobile-outreach clinics using a paediatric dispersible formulation of SP, alongside routine vaccinations and vitamin A supplementation. Children will receive up to a maximum of 6 doses of IPTi in the first two years of life.

Through this implementation, capacity will be built and fundamental programmatic issues to achieving effectiveness will be assessed, including:

  • IPTi operational feasibility and acceptability;
  • impact on health services integration, i.e. on EPI immunisations and vitamin A administration coverage;
  • the cost and cost-effectiveness of IPTi delivery including through the outreach EPI platform;
  • the impact on malaria incidence, anaemia, overall mortality, SP resistance development and the safety of the intervention.

The integration of IPTi with EPI contacts, together with social and behaviour change communication campaigns to inform communities of the importance of EPI, and the malaria protection afforded by IPTi delivered at the EPI, could lead to an increased demand for EPI.

Total Funding

4,722,431 €

 

This project is part of the EDCTP2 programme supported by the European Union

 

 

Our Team

Coordinator

  • Clara Menéndez
    Clara Menéndez Research Professor, Director of the Maternal, Child and Reproductive Health Initiative and Programme

ISGlobal Team

Other projects

See Past Projects

MESA

The Malaria Eradication Scientific Alliance - MESA is dedicated to advancing the science of malaria eradication.

RTS,S Vaccine Immunology Study

Study of immune correlates of protection against malaria after vaccination with RTS,S/AS01E: a comprehensive immunological arm of a Phase III double-blind, randomized, controlled multi-center trial

MiPMon

Pregnant women as a sentinel group for malaria surveillance in an era of changing malaria transmission

AlphaGal

Exploration of the singularities of the sugar nucleotide metabolism and description of novel glycosylation pathways in the malaria parasite

TIPTOP

Transforming IPT for optimal pregnancy

NANOpheles

Development of nanovectors for the targeted delivery in Anopheles mosquitoes of agents blocking transmission of Plasmodium parasites

BOHEMIA

Broad One Health Endectocide-based Malaria Intervention in Africa

ASINTMAL

Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults

GenMoz

P. falciparum genomic intelligence in Mozambique

ADAM

Malaria mass and focal drug administration to advance malaria elimination in Mozambique: accelerating programmatic implementation and policy translation

ECO

Enhanced and equitable coverage of COVID-19 testing and treatment in Bolivia and Paraguay

CaDMIA-plus

Continued validation of the minimally invasive autopsy for the investigation of the causes of death in infants, and establishment of a research and training center to study causes of death

METRO

Measuring community prevalence among HIV exposed children in rural Southern Mozambique

MAMAH

Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women

ICARIA

Improving Care through Azithromycin Research for Infants in Africa

MIBio

Identification of Prematurity and Pre-Eclampsia as Causes of Mortality

STREESCO

Strengthening Epidemiological Surveillance in Benin and Burkina Faso for an Effective Response to COVID-19

MA-CoV

Prevalence and impact of SARS-CoV-2 infection on maternal and infant health in African populations